FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and represents a vaccine composition for inducing an immune response in animals. The composition contains an antigen and a 40% oil-in-water emulsion diluted to 2.5%, wherein the above 40% oil-in-water emulsion contains 30 vl/vl % of light hydrocarbon non-metabolic oil, 10 vl/vl % of lecithin, 0.6 vl/vl % of sorbitan monooleate, 1.4 vl/vl % of polyoxyethylene sorbitan monooleate; the oil component is dispersed in an aqueous component by emulsification, while the vaccine composition is prepared by a microfluidiser. An average drop size in the composition makes less than 0.3 mcm.
EFFECT: composition possesses improved physical characteristics, enhanced immunising action, as well as high safety.
10 cl, 20 ex, 17 tbl, 11 dwg
Title | Year | Author | Number |
---|---|---|---|
MICROFLUIDISED OIL-IN-WATER EMULSIONS AND VACCINE COMPOSITIONS | 2005 |
|
RU2347586C2 |
NEW ADJUVANT COMPOSITIONS | 2009 |
|
RU2510280C2 |
OIL-BASED ADJUVANTS | 2014 |
|
RU2730011C2 |
OIL-BASED ADJUVANTS | 2014 |
|
RU2816849C2 |
LIPOSOMAL ADJUVANT COMPOSITIONS | 2016 |
|
RU2736642C2 |
COMBINED VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE | 2013 |
|
RU2615443C2 |
COMBINATION VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE/PRRS (PCV/MYCOPLASMA HYOPNEUMONIAE/PRRS COMBINATION VACCINE) | 2013 |
|
RU2644256C2 |
MYCOPLASMA HYOPNEUMONIAE VACCINE | 2013 |
|
RU2644254C2 |
VACCINES AND METHODS OF TREATING CANINE INFLUENZA | 2006 |
|
RU2396976C2 |
VACCINE AGAINST INFECTIOUS BRONCHITIS | 2017 |
|
RU2781143C2 |
Authors
Dates
2015-02-20—Published
2004-03-22—Filed